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A B S T R A C T
Galium aparine L. is a very disseminated plant in temperate zones, commonly known as clivers or bedstraw,
belonging to the Rubiaceae family and it is traditionally used for its medicinal applications. In this study, G.
aparine hydromethanolic extracts and infusions were prepared from air-dried and freeze-dried samples in order
to assess their phenolic profile, antioxidant, antimicrobial, and cytotoxic properties. All the studied extracts
revealed a similar phenolic profile, but the hydromethanolic extract obtained from the freeze-dried sample
presented the highest concentration of phenolic compounds, followed by the respective infusion and the air-
dried sample hydromethanolic extract. The major compound detected in the extracts was 5-O-caffeoylquinic acid
(from 145 to 163mg/g extract). Regarding the bioactivity, in general, the extracts presenting higher phenolic
concentrations also revealed enhanced bioactive properties. The EC50 values obtained in the antioxidant activity
assays ranged from 13.5 to 884 μg/mL, with the freeze-dried sample hydromethanolic extract presenting the
highest activity (13.5–555 μg/mL). Similar conclusions could be made in terms of antimicrobial properties, with
this extract showing the lowest MIC (1.85–15mg/mL), MBC (3.75–7.5 mg/mL), and MFC (3.75–20mg/mL)
values. None of the extracts revealed cytotoxicity. The results obtained in this study suggested that G. aparine
extracts can be a good source of phenolic compounds with antioxidant and antimicrobial properties.
1. Introduction
There are 350,000 plant species in the world, among which about
80,000 edible and yet, it is estimated that only about 150 species are
cultivated, directly for human consumption or as a feed for animals
(Füleky, 2009). Numerous plant species that could provide excellent
sources of foodstuff as part of a balanced diet, pharmaceutical products,
insecticides, food additives such as colorants and flavourings, or even a
raw ingredient for the preparation of beverages, remain underutilized
(Haq, 1993).
It is well-known that polyphenol-rich foods and beverages may in-
crease plasma antioxidant capacity, and plants are considered rich
sources of these secondary metabolites, with a variety of more than
8000 such compounds identified from various plant species (Pandey
and Rizvi, 2009). Moreover, epidemiological data indicates that the
long term consumption of diets rich in plant polyphenols offers a pro-
tection against the development of cancers, diabetes, osteoporosis,
cardiovascular and neurodegenerative diseases (Pandey and Rizvi,
2009; Young and Woodside, 2001). The ability of these natural
antioxidants to delay oxidation processes in foodstuffs and biological
membranes has recently focused much attention (Lindsey et al., 2002;
Vlase et al., 2014), which has led to an increased antioxidant assess-
ment of many medicinal and food plant species (Abbasi et al., 2015). In
this matter, the traditional knowledge plays an essential role on the
identification of plants that may be useful, however, in many instances
most of this knowledge survives in the people’s memory and is now in
danger of disappearing (Fabricant and Farnsworth, 2001; Fennell et al.,
2004; Jyotsna and Katewa, 2016).
Galium aparine L. (Rubiaceae), commonly known as clivers or bed-
straw is a common weed in temperate zones on all continents and in
Europe, it occurs from Portugal in the west to Russia in the east, and
from the UK in the north to Italy in the south (CABI, 2018). It is an
unwanted and troublesome plant species in cereal, rapeseed and sugar
beet fields where it is noted for its detrimental impact on the potential
yields (Malik and Born, 1988). Traditionally, G. aparine has enjoyed a
large number of medicinal applications for diverse health conditions.
Briefly, the whole herb (stem, leaf, flower and seed) has been com-
monly used as cooling diuretic in fevers and for urinary tract infections,
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in skin diseases such as eczema or psoriasis, ulcers, chronic sores, as a
blood purifier i.e., to increase lymphatic flow, to reduce swellings, in-
fection and inflammation, or to stop bleeding from wounds (Tobyn
et al., 2016).
Beyond these applications, in Sweden, roasted seeds of G. aparine
were used as a coffee substitute (Malik and Born, 1988) and in Turkey,
young shoots of G. aparine are also eaten roasted (Taskin and Bitis,
2016) and used to coagulate milk, being known as “yogurt herb”
(Aslantürk et al., 2017; Deliorman et al., 2001). Although the herb has
long history of its use in phytotherapy, and the contemporary time’s
herbalists continue to use it as a diuretic, the pharmacological evidence
supporting this efficiency is scarce. According to some reports, this
plant is a source of polyphenols (Moubasher et al., 2016; Vlase et al.,
2014), phytosterols (Mocan et al., 2016), alkaloids, anthraquinones,
saponins (Aslantürk et al., 2017), sesquiterpenoids, squalene, aromatic
compounds, higher alkanes (and derivatives), fatty acids, chlorophylls,
carotenoids and iridoids (Deliorman et al., 2001; Goryacha et al.,
2014).
In order to establish scientific rationale for the use of G. aparine, the
first aim of this study was to investigate the phenolic profile, anti-
oxidant, antimicrobial and cytotoxic properties of hydromethanolic
extracts and infusions prepared from this plant species. Furthermore,
since medicinal plants are often dried and sold as semi- and processed
products, in this study, a freshly harvested botanical material was
prepared by air-drying and freeze-drying with the objective of ex-
amining the effect of the drying method on the phenolic composition
and bioactive properties of G. aparine.
2. Material and methods
2.1. Samples and samples preparation
Galium aparine L. (Rubiaceae) was collected at various growth stages
in order to prepare a homogeneous sample, in June 2017, from the
campus of the Polytechnic Institute of Bragança, Portugal. The collected
plant material was authenticated by Professor of Botany Carlos Aguiar
and a specimen voucher was deposited in the herbarium of the School
of Agriculture, Polytechnic Institute of Bragança (Portugal).
The vegetal material (leaves, stems, flowers and seeds) was sub-
jected to two drying methods, i.e., air-drying (one week, at room
temperature, in the dark) and freeze-drying (lyophilisation; FeeeZone
4.5, Labconco, Kansas City, MO, USA). The dried samples were reduced
to fine and homogeneous powder (∼20mesh) and stored at room
temperature, protected from direct light, for further analysis.
2.2. Extracts preparation
For each sample, infusions and hydromethanolic extracts were
prepared in order to compare the phenolic composition and bioactive
properties of extracts obtained from different procedures, using thermal
and nonthermal extractions, and solvents with different polarities, once
the extracted compounds are dependent of these conditions. Regarding
infusions, air-dried and freeze-dried samples (1 g) were infused with
freshly boiled distilled water (100mL), left aside for 5min and subse-
quently filtered through filter paper. The resulting extracts were then
freeze-dried and a yield of 21.9 and 27.4% was obtained for air-dried
and freeze-dried samples, respectively.
For the preparation of the hydromethanolic extracts, the samples
(1 g) were extracted by stirring (150 rpm) with 30mL of methanol:-
water (80:20, v/v) at room temperature for 1 h, and subsequently fil-
tered through filter paper. The residue was then extracted with an ad-
ditional 30 mL portion of methanol:water (80:20, v/v) and filtered.
Methanol was evaporated at 40 °C under reduced pressure (Rotavac
Valve Tec, Germany) and the remaining supernatant was freeze-dried.
The extraction yield was of 23.9 and 22.7% for air-dried and freeze-
dried samples, respectively.
2.3. Phenolic compounds
The phenolic profile was determined by LC-DAD-ESI/MSn (Dionex
Ultimate 3000 UPLC, Thermo Scientific, San Jose, CA, USA). The lyo-
philized infusions and hydromethanolic extracts were re-dissolved in
water and methanol/water mixture (80:20, v/v), respectively, at a
concentration of 5mg/mL. Double online detection was used using a
DAD (280, 330, and 370 nm as preferred wavelengths) and in a mass
spectrometer in negative mode, equipped with an ESI source (Linear Ion
Trap LTQ XL mass spectrometer, Thermo Finnigan, San Jose, CA, USA),
as previously described by Bessada et al. (2016).
The identification of the phenolic compounds was performed using
standard compounds, when available, by comparing their retention
times, UV–vis and mass spectra; and also comparing the obtained in-
formation with available data reported in the literature, giving a ten-
tative identification, when no standards were available. For quantita-
tive analysis, calibration curves (5–100 μg/mL) for each available
phenolic standard (5-O-caffeoylquinic acid≥ 99%, p-coumaric
acid≥ 90%, ferulic acid≥ 90%, and quercetin-3-O-rutinoside≥ 99%
HPLC purity, Extrasynthèse, Genay, France) were constructed based on
the UV signal. For the identified phenolic compounds for which a
commercial standard was not available, the quantification was per-
formed through the calibration curve of the most similar available
standard (Table 1). The results were expressed as mg/g of extract.
2.4. Antioxidant activity
For the antioxidant activity assessment, the lyophilized infusions
and hydromethanolic extracts were re-dissolved in water and me-
thanol/water mixture (80:20, v/v), respectively, at a final concentra-
tion of 10mg/mL. These stock solutions were further diluted to perform
the bellow described assays.
2.4.1. DPPH radical-scavenging activity assay
DPPH radical-scavenging activity was assessed using BioTek
ELX800 microplate Reader (Bio-Tek Instruments, Inc.; Winooski, USA).
The reaction mixture in each of the 96 wells consisted of the infusions
and hydromethanolic extracts at different concentrations (30 μL) and
methanolic solution (270 μL) containing DPPH radicals (6× 10−5 mol/
L). The mixture was left to stand for 60min in the dark and at room
temperature. The absorbance was measured at 515 nm to assess the
reduction of DPPH radicals, which was calculated as a percentage of
DPPH discolouration using the formula: [(A DPPH−A S)/A DPPH]× 100,
where A S is the absorbance of the solution containing the sample, and
A DPPH is the absorbance of the DPPH solution (Rita et al., 2016).
2.4.2. Reducing power
In order to assess the capacity to convert Fe3+ into Fe2+, samples
solutions at different concentrations (0.5 mL) were mixed with sodium
phosphate buffer (200mmol/L, pH 6.6, 0.5mL) and potassium ferri-
cyanide (1% w/v, 0.5mL). The resulting mixtures were incubated at 50°
C for 20min, and trichloroacetic acid (10% w/v, 0.5mL) was added.
The supernatant (0.8 mL) was then poured in a 46-well microplate
along with deionised water (0.8 mL) and ferric chloride (0.1% w/v).
The reducing power was assessed through the absorbance at 690 nm,
using the microplate reader mentioned above (Rita et al., 2016).
2.4.3. Inhibition of β-carotene bleaching assay
The β-carotene bleaching inhibition was assessed by measuring the
capacity of the extracts and infusions to neutralise linoleate free radi-
cals. A β-carotene solution was obtained by dissolving β-carotene
(2mg) in chloroform (10mL), and evaporated (Rotavac Valve Tec,
Germany) in a round bottom flask at 40 °C under reduced pressure.
Linoleic acid (0.2 g), Tween 80 (2 g) and distilled water (0.5 L) were
added to the flask with vigorous shaking. Aliquots (4.8 mL) of the re-
sulting emulsion were transferred into the test tubes containing
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different concentrations of infusions and hydromethanolic extracts,
vortexed and the absorbance (T0) was measured at 470 nm. After 2 h of
incubation at 50 °C in a water bath with agitation (100 rpm), the ab-
sorbance (T1) was measured again. β-carotene bleaching inhibition was
calculated using the equation: Absorbance (T1)− Absorbance
(T0)× 100 (Rita et al., 2016).
2.4.4. Lipid peroxidation inhibition by thiobarbituric acid reactive substance
(TBARS) assay
The porcine (Sus scorfa) brain tissue was obtained from local
slaughter house, dissected and homogenized with cold Tris-HCl
(20mM, pH 7.4) buffer solution. The brain tissue homogenate was
produced in ratio 1:2 w/v and centrifuged at 3000g for 10min. An
aliquot (100 μL) of the supernatant was incubated with the sample so-
lutions at different concentrations in the presence of FeSO4 (10mM,
100 μL) and ascorbic acid (0.1 mM, 100 μL) at 37 °C for 1 h. The reac-
tion was stopped by the addition of trichloroacetic acid (28% w/v,
500 μL) and a solution of thiobarbituric acid (TBA, 2% w/v, 380 μL)
was added. The samples were incubated at 80 °C for 20min and cen-
trifuged (3000g, 5 min) in order to remove precipitated proteins. The
absorbance of the pink malondialdehyde (MDA)–TBA complex in the
supernatant was measured at 532 nm, and the inhibition ratio (%) was
determined using the equation: Inhibition ratio (%)= [(A–B)× 100]
where A is the absorbance of the control sample, and B is the absor-
bance of the sample solution (Svobodova et al., 2017).
2.5. Cytotoxicity
For the cytotoxicity assessment, the lyophilized infusions and hy-
dromethanolic extracts were re-dissolved to a final concentration of
1000 μg/mL. The hepatotoxicity was assessed using a non-tumour liver
primary culture established in our laboratory, PLP2, prepared from a
freshly harvested porcine liver obtained from a local slaughter house.
The cell line was plated at 1.0× 104 cells/well in 96-well plates and
sulforhodamine B assay was performed according to a procedure pre-
viously described by the authors (Guimarães et al., 2013). The results
were expressed in GI50 values (sample concentration that inhibited 50%
of the net cell growth). Ellipticine was used as positive control.
2.6. Antimicrobial activity
For the antimicrobial activity assessment, the lyophilized infusions
and hydromethanolic extracts were re-dissolved in 5% DMSO, at a final
concentration of 30mg/mL. These stock solutions were further diluted
to perform the bellow described assays.
2.6.1. Antibacterial activity
Antibacterial activity was assessed against Gram-negative bacteria:
Escherichia coli (ATCC 35210), Salmonella typhimurium (ATCC 13311),
Salmonella enteritidis (ATCC 13076), Enterobacter cloacae (ATCC 35030),
and Gram-positive bacteria: Staphylococcus aureus (ATCC 6538),
Bacillus cereus (clinical isolate), Micrococcus flavus (ATCC 10240), and
Listeria monocytogenes (NCTC 7973), following a previously described
procedure (Soković et al., 2010). The minimum inhibitory (MIC) and
minimum bactericidal (MBC) concentrations were determined ac-
cording to the referred reference. Streptomycin and ampicillin were
used as positive controls.
2.6.2. Antifungal activity
Antifungal activity was evaluated against Aspergillus fumigatus
(ATCC 1022), Aspergillus ochraceus (ATCC 12066), Aspergillus versicolor
(ATCC 11730), Aspergillus niger (ATCC 6275), Candida krusei (IBRS
1flac1), Penicillium funiculosum (ATCC 36839), Penicillium ochrochloron
(ATCC 9112), and Penicillium verrucosum var. cyclopium (food isolate),
following the procedure previously described by the authors (Soković
and Van Griensven, 2006). The minimum inhibitory (MIC) and
minimum fungicidal (MFC) concentrations were obtained following the
same reference. Ketokonazole and bionazole were used as positive
controls.
2.7. Statistical analysis
For each drying treatment (air-dried and freeze-dried), three in-
dependent samples were analysed and all assays were carried out in
triplicate. Data were expressed as mean ± standard deviation. A 5%
significance level, using IBM SPSS Statistics for Windows, version 23.0.
(IBM Corp., Armonk, NY, USA), was applied to all statistical tests. The
fulfilment of the one-way ANOVA requirements, specifically the normal
distribution of the residuals (data not shown) and the homogeneity of
variance, was tested by means of the Shapiro Wilk’s and the Levene’s
tests, respectively. Depending on the homoscedasticity, the dependent
variables were compared using Tukey’s honestly significant difference
(HSD; when homoscedastic) or Tamhane’s T2 multiple comparison
(when no homoscedastic) tests.
3. Results and discussion
3.1. Phenolic compounds
Phenolic compounds identification was carried out considering their
retention times, whenever possible in comparison with commercially
available standards, and both UV and MS spectra. Data obtained by
HPLC-DAD-ESI/MS analysis (retention time, λmax, pseudomolecular
ion, main fragment ions in MS2), phenolic compounds identification,
and respective quantification are present in Table 1. Six compounds
were found in G. aparine hydromethanolic extracts and infusions,
among which four phenolic acids, a flavonol and a lignin. All the ex-
tracts revealed similar profiles, only differing in the detected com-
pounds content. The freeze-dried sample hydromethanolic extract was
the one revealing the highest total phenolic compounds concentration
(191mg/g extract; chromatogram shown in Fig. 1), followed by the
respective infusion and the air-dried sample hydromethanolic extract
that presented similar phenolic amounts (183 and 181mg/g extract,
respectively). The most abundant compound in all the assessed extracts
was 5-O-caffeoylquinic acid, in concentrations of about 85–88% of the
total phenolic compounds content. All the compounds detected were
present in higher amounts in the freeze-dried sample hydromethanolic
extract, with the exception of 5-O-coumaroylquinic acid that was most
abundant in this sample infusion (3.3 mg/g extract), and 5-O-fer-
uloylquinic acid that was mostly detected in both air-dried sample ex-
tracts (5.37 mg/g of hydromethanolic extract and 5.3mg/g of infusion).
Compounds 1 (5-O-caffeoylquinic acid) and 6 (quercetin-3-O-ruti-
noside) were positively identified according to their retention time,
mass, and UV–vis characteristics by comparison with commercial
standards. These compounds were also previously detected in samples
of G. aparine ethanolic extracts (Vlase et al., 2014). Compounds 2
(caffeoylquinic acid), 3 (5-O-coumaroylquinic acid), and 4 (5-O-fer-
uloylquinic acid) were identified taking into account the recommended
IUPAC numbering system (IUPAC, 1976) as also the hierarchical keys
previously developed by Clifford et al. (2005, 2003). Compound 5, was
tentatively identified as a lignin, taking into account the fragmentation
patterns reported by Morreel et al. (2014), that also observed MS2
fragments at m/z 519, followed by m/z 357 (−162 u) resulting from
hexose loss, and m/z 339 (−18 u) and 327 (−30 u) that could be ex-
plained by water and formaldehyde losses, respectively. According to
the authors, these type I fragmentations are typically observed in the
spectrum of phenylcoumarans, which has led to the tentative identifi-
cation of this compound as phenylcoumaran hexoside.
In a study performed by Vlase et al. (2014), G. aparine ethanolic
extracts presented six phenolic acids (caftaric, gentisic, caffeic,
chlorogenic, p-coumaric, and ferulic acids) and five flavonoids (hy-
peroside, isoquercitrin, rutin, quercetin, and luteolin), with rutin,
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quercetin, and ferulic acid (7.983, 5.679, and 3.793mg/100 g dw, re-
spectively) as the most abundant compounds. These authors also stu-
died three other Galium species, namely Galium verum, Galium mollugo,
and Galium odoratum and despite G. aparine presented the largest
variety of phenolic compounds, G. verum was the species revealing the
highest total phenolic concentration, followed by G. mollugo, G. aparine,
and G. odoratum (894, 31, 21, and 17mg/100 g dw, respectively). Other
studies also evaluated G. aparine water extracts (Abbasi et al., 2015)
and aqueous fractions (Bokhari et al., 2013) in terms of total phenolics
and the water extracts contained 24mg GAE/100 g fw, whereas the
aqueous fractions revealed a slightly lower amount of 22.1 mg GAE/g of
dried fraction.
3.2. Antioxidant activity and cytotoxicity
The antioxidant activity results of the G. aparine infusions and hy-
dromethanolic extracts are presented in Table 2. In general, the freeze-
dried sample hydromethanolic extract revealed lower EC50 values
(ranging from 13.5 to 555 μg/mL), indicating a stronger antioxidant
activity, except for the DPPH scavenging activity assay, where the in-
fusion obtained from the air-dried sample gave better results (EC50
value of 467 μg/mL). This latest also revealed higher reducing power
and β-carotene bleaching inhibition capacity (EC50 values of 267.7 and
109 μg/mL, respectively) than the freeze-dried sample hydromethanolic
extract and the air-dried sample infusion. Nevertheless, regarding the
TBARS inhibition capacity, the air-dried sample hydromethanolic ex-
tract presented the best results (EC50 value of 221 μg/mL), following the
freeze-dried sample hydromethanolic extract. Comparing the results
obtained for the different extracts of G. aparine with those of trolox
(positive control), the hydromethanolic extract of the freeze-dried
sample was the only one revealing a lower EC50 value (13.5 and 23 μg/
mL for the extract and the positive control, respectively), in the TBARS
inhibition assay. In a study performed with several G. aparine extract
fractions, the butanol, methanol, and aqueous fractions revealed DPPH
scavenging activity at 61.7, 75, and 58.3 μg/mL, respectively, which
represent concentrations ten times lower than those obtained in the
present study (Bokhari et al., 2013). On the other hand, in a study
performed by Abbasi et al. (2015), water and acetone extracts of G.
aparine showed approximately 69 and 55% DPPH scavenging activity,
respectively, in concentrations of 100mg/mL dw, but once again, it was
not possible to compare these results to those achieved herein because
of the methodology discrepancies along with the differences on the
results analysis and presentation.
Regarding cytotoxicity evaluation (Table 2), none of the G. aparine
extracts revealed toxicity in the assessed porcine liver cells primary
culture, PLP2, at the studied concentration (1000 μg/mL), which sup-
port the use of this plant extracts without associated toxicity effects.
3.3. Antimicrobial activity
The results obtained in the screening of antimicrobial activity of G.
aparine extracts against the studied bacteria and fungi are shown in
Table 3. The antibacterial activity of the extracts was tested against
eight bacterial strains: B. cereus,M. flavus, S. aureus, L. monocytogenes, E.
coli, E. cloacae, S. enteritidis, and S. typhimurium. Generally, all the ex-
tracts revealed inhibitory and bactericidal capacity in concentrations
Fig. 1. Phenolic profile of Galium aparine L. freeze-dried sample hydromethanolic extract, recorded at 280 nm. Peak numbering is in accordance with Table 1.
Table 2
Antioxidant activity and cytotoxicity of Galium aparine L. infusions and hydromethanolic extracts (mean values ± SD).
Freeze-dried Air-dried p-value (n= 36) Positive control
Hydromethanolic extract Infusion Hydromethanolic extract Infusion Homoscedasticitya 1-way ANOVAb
Antioxidant activity (EC50 values, μg/mL)
DPPH scavenging activity 555 ± 4b 554 ± 11b 884 ± 12a 467 ± 3c 0.002 < 0.001 41 ± 1
Reducing power 175.2 ± 0.2d 327 ± 1b 365 ± 3a 267.7 ± 0.6c 0.001 < 0.001 41.7 ± 0.3
β-carotene bleaching inhibition 83 ± 1d 128 ± 4b 143 ± 8a 109 ± 2c 0.001 < 0.001 18 ± 1
TBARS inhibition 13.5 ± 0.8d 525 ± 2a 221 ± 3c 404 ± 6b 0.001 < 0.001 23 ± 1
Citotoxicity (GI50 values, μg/mL)
PLP2 >1000 >1000 >1000 >1000 – – 3.2 ± 0.7
nd – not detected.
Trolox and ellipticine were used as positive control for the antioxidant activity and cytotoxicity assays, respectively.
a Homoscedasticity among the different drying process and extraction method was tested by the Levene test: homoscedasticity, p > 0.05; heteroscedasticity,
p < 0.05.
b p < 0.05 indicates that the mean value of at least one component differs from the others (in this case, multiple comparison tests were performed). For each
different sample, different letters within a line means they differ significantly (p < 0.05).
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ranging from 1 to 15 and 1.85 to 30mg/mL, respectively. Nevertheless,
the infusions did not show the capacity to inhibit E. coli, at the studied
concentrations (30mg/mL). The extract revealing higher antibacterial
properties, with lowest MIC and MBC values, was the freeze-dried
sample hydromethanolic extract, which inhibited S. aureus, L. mono-
cytogenes, E. cloacae, S. enteritidis, and S. typhimurium growth in a con-
centration of 1.85mg/mL and B. cereus, M. flavus, and E. coli at
3.75mg/mL. The MBC values presented by this extract varied from 3.75
to 7.5mg/mL. B. cereus was the strain revealing the highest sensitivity
to the extracts, with MIC and MBC values of 1 and 1.85mg/mL when
exposed to the air-dried sample hydromethanolic extract. This extract
showed the second strongest antibacterial activity, considering all the
studied bacteria, after the other hydromethanolic extract. As the most
resistant bacterial strain, S. typhimurium needed MIC and MBC values
ranging from 1.85 to 15 and 3.75 to 30mg/mL, respectively. All the
MIC and MBC values obtained for the positive controls were higher than
those presented by the extracts. As far as we know, there are no reports
on the antimicrobial activity of this plant infusions nor hydro-
methanolic extracts, which did not allow a comparison of the results
obtained in the present study to other literature data. Nonetheless, an
ethanol tincture of G. aparine desiccated stems produced an average
zone of clearance of 2mm (at a concentration of 27mg/mL), while
aqueous extracts did not reveal activity against S. aureus, in a study
performed by Romero et al. (2005) using Kirby-Bauer disk diffusion
susceptibility analysis to assess the antimicrobial activity. Otherwise,
Zhao et al. (2006) investigated the antimicrobial activity of 2,5-dihy-
droxy-1,3-dimethoxyanthraquinone isolated from an G. verum ethanolic
extract, through the filter paper method, and reported a moderate ac-
tivity against E. coli (12mm), Salmonella aureus (14mm), Pseudomonas
aeruginosa (13mm), and S. typhimurium (14mm). Moreover, various
Galium mexicanum aerial parts extracts (chloroform and methanol ex-
tracts) and fractions (hexane, chloroform, and methanol fractions) were
found to possess antimicrobial activity against Bacillus subtilis, methi-
cillin-resistant S. aureus, S. aureus, and Streptococcus pyogenes, in con-
centrations ranging from 166 to 666 μg/mL, except for the hexane
fraction that inhibited S. aureus growth at 67 μg/mL (Bolivar et al.,
2011).
In what concerns the antifungal activity of G. aparine extracts, eight
fungi were assessed: A. fumigatus, A. versicolor, A. ochraceus, A. niger, C.
krusei, P. funiculosum, P. ochrochloron, and P. verrucosum. Similar to the
results obtained in the antibacterial activity assessment, the hydro-
methanolic extracts also revealed higher antifungal activity than the
infusions, with the freeze-dried sample showing the lowest MIC and
MFC values, which ranged from 1.85 to 15 and 3.75 to 20mg/mL, re-
spectively. The freeze-dried sample infusion showed the capacity to
inhibit the growth of A. versicolor, A. ochraceus, and P. funiculosum, in
concentrations of 7.5, 15, and 30mg/mL, respectively, and also pre-
sented fungicidal properties in A. versicolor and A. ochraceus (MFC va-
lues of 15 and 30, respectively). On the other hand, the air-dried sample
infusion showed MIC values of 15 mg/mL in A. versicolor and A.
ochraceus, and 30mg/mL in A. fumigatus, C. krusei, P. funiculosum, P.
ochrochloron, and P. verrucosum, but did not present fungicidal activity
at the tested concentration (30mg/mL). All the studied fungi were
sensitive to the hydromethanolic extracts and the major differences
Table 3
Antimicrobial activity of Galium aparine L. infusions and hydromethanolic extracts.
Freeze-dried Air-dried Positive control 1 Positive control 2
Hydromethanolic extract Infusion Hydromethanolic extract Infusion
Antibacterial activity (MIC and MBC values, mg/mL)
Bacillus cereus 3.75 3.75 1 3.75 0.1 0.25
7.5 15 1.85 7.5 0.2 0.4
Micrococcus flavus 3.75 3.75 3.75 3.75 0.2 0.25
7.5 15 7.5 7.5 0.3 0.4
Staphylococcus aureus 1.85 3.75 3.75 10 0.04 0.25
3.75 15 7.5 20 0.1 0.45
Listeria monocytogenes 1.85 10 3.75 7.5 0.2 0.4
7.5 20 15 20 0.3 0.5
Escherichia coli 3.75 > 30 10 >30 0.2 0.4
7.5 > 30 15 >30 0.3 0.5
Enterobacter cloacae 1.85 15 3.75 7.5 0.2 0.25
7.5 30 7.5 15 0.3 0.5
Salmonella enteritidis 1.85 15 7.5 3.75 0.15 0.3
3.75 20 15 7.5 0.3 0.6
Salmonella typhimurium 1.85 15 3.75 7.5 0.25 0.4
3.75 30 7.5 20 0.5 0.75
Antifungal activity (MIC and MFC values, mg/mL)
Aspergillus fumigatus 15 >30 7.5 30 0.25 0.15
20 >30 15 >30 0.5 0.2
Aspergillus versicolor 1.85 7.5 3.75 15 0.2 0.1
3.75 15 7.5 >30 0.5 0.2
Aspergillus ochraceus 3.75 15 1.85 15 1.5 0.15
7.5 30 3.75 >30 2 0.2
Aspergillus niger 3.75 > 30 3.75 >30 0.2 0.15
7.5 > 30 7.5 >30 0.5 0.2
Candida krusei 3.75 > 30 3.75 30 0.075 0.05
7.5 > 30 7.5 >30 0.15 0.1
Penicillium funiculosum 3.75 30 3.75 30 0.2 0.2
7.5 > 30 7.5 >30 0.5 0.25
Penicillium ochrochloron 3.75 > 30 10 30 2.5 0.2
7.5 > 30 15 >30 3.5 0.25
Penicillium verrucosum var. cyclopium 7.5 > 30 10 30 0.2 0.1
15 > 30 30 >30 0.3 0.2
MIC: Minimum Inhibitory concentration; MBC: Minimum bactericidal concentration; MFC: Minimal fungicidal concentration.
As positive controls, streptomycin and ampicillin (positive control 1 and 2, respectively) were used for the antibacterial activity, while ketoconazole and bifonazole
(positive control 1 and 2, respectively) were used for antifungal activity.
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between MIC and MFC values were observed for P. verrucosum in the
presence of the air-dried sample hydromethanolic extract, where MFC
(30mg/mL) was the triple of the MIC value. The antifungal activity of
the positive controls was higher than that of the extracts, but both
hydromethanolic extracts presented MIC and MFC values close to those
obtained for ketoconazole (positive control 1) in what concerns P.
ochrochloron and A. ochraceus, respectively.
To the best of our knowledge, this is the first work on the antifungal
activity of G. aparine extracts. Nevertheless, Bolivar et al. (2011) stu-
died G. mexicanum extracts and fractions and demonstrated the ability
of some hexane and methanol fractions to inhibit the growth of Tri-
chophyton rubrum and Cryptococcus neoformans, when concentrated at
333–500 and 333–999 μg/mL, respectively, while a chloroform fraction
exhibited activity in Candida albicans at 666 μg/mL; none of the as-
sessed extracts (chloroform and methanol extracts) revealed anti-
microbial properties. Similarly, G. verum methanolic extracts did not
reveal antifungal activity in a study performed with several Candida
species (Yiǧit et al., 2009), contrarily to G. aparine hydromethanolic
extracts assessed in the present study that showed the capacity to in-
hibit the growth of eight fungi, also revealing fungicidal properties.
4. Conclusion
Four extracts (two hydromethanolic extracts and two infusions) of
G. aparine samples subjected to different drying procedures (freeze-
drying and air-drying) were assessed for their phenolic profile and re-
lated bioactive properties. Generally, the samples presenting the
highest levels of phenolic compounds also demonstrated higher bioac-
tive properties. The freeze-dried sample hydromethanolic extract was
the outstanding extract in terms of total phenolic concentration, anti-
oxidant, antibacterial, and antifungal properties. None of the extracts
revealed hepatotoxicity. The present study provides valuable informa-
tion regarding G. aparine, contributing to the valorization of this Galium
species, commonly known as an undesired and troublesome weed in
several cultivars, and which previous reports are scarce.
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